skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Blood thinning drug to treat recovery from severe COVID-19 is not effective

Blood thinning drug to treat recovery from severe COVID-19 is not effective

30 November 2022

A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge has found. This finding is important because it will prevent unnecessary harm...


Read more at: Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead

Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead

9 November 2022

Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease. This could transform the way we treat Parkinson’s disease Roger Barker The Swedish Medical Products Agency has granted approval for the trial...


Read more at: Set up reserve lab capacity now for faster response to next pandemic, say researchers

Set up reserve lab capacity now for faster response to next pandemic, say researchers

12 October 2022

Researchers say a ‘human bottleneck’, due to historical cuts in public health funding, delayed the UK’s scale-up of COVID-19 testing in the early stages of the country’s pandemic response. A pandemic like COVID-19 is guaranteed to happen again at some point. Jordan Skittrall The researchers, who were on the front line of...


Read more at: Cambridge researchers elected as members of European Molecular Biology Organisation

Cambridge researchers elected as members of European Molecular Biology Organisation

7 September 2022

Five Cambridge researchers join the community of more than 1,900 leading life scientists in Europe and beyond today as the European Molecular Biology Organisation (EMBO) announces its newly-elected Members. EMBO Members are recognised for their outstanding achievements in the life sciences. The newly elected members reside...


Read more at: AstraZeneca to fund a further 55 PhD studentships with University of Cambridge

AstraZeneca to fund a further 55 PhD studentships with University of Cambridge

20 July 2022

The University of Cambridge has formed a new agreement with AstraZeneca for the global biopharmaceuticals company to fund 55 additional PhD studentships over the next five years, starting in October 2022. Over the last 20 years, AstraZeneca has funded more than 100 PhD students from the University as part of a longstanding...


Read more at: "There isn’t anything like it in the UK" The new institute tackling some of the world's biggest killers

"There isn’t anything like it in the UK" The new institute tackling some of the world's biggest killers

20 July 2022

A major new institute opens today, bringing together the largest concentration of scientists and clinicians in heart and lung medicine in Europe. On 18 August 1979, Keith Castle – despite being described by surgeon Sir Terence English as "not an ideal patient from a medical point of view" – made history, becoming the first...


Read more at: Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants

Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants

28 April 2022

Long term use of implantable medical devices- such as pacemakers and cochlear implants- is hampered by the body's reaction to foreign bodies. now, in a study in mice, a team led by scientists at the University of Cambridge has shown that this reaction can be dramatically reduced by incorporating an anti-inflammatory drug...


Read more at: Cambridge spin-out receives European Innovation Council grant to develop cancer imaging technologies

Cambridge spin-out receives European Innovation Council grant to develop cancer imaging technologies

23 February 2022

Spin-off company Cambridge Raman Imaging Ltd. and the Cambridge Graphene Centre will lead ‘CHARM’ project, recently awarded with €3.2 million Funding from the European Union is an integral part of the Cambridge Graphene Centre’s success Andrea Ferrari The European Innovation Council (EIC) has awarded the first Transition...


Read more at: Study in mice shows potential for gene-editing to tackle mitochondrial disorders

Study in mice shows potential for gene-editing to tackle mitochondrial disorders

16 February 2022

Defective mitochondria – the ‘batteries’ that power the cells of our bodies – could in future be repaired using gene-editing techniques. Scientists at the University of Cambridge have shown that it is possible to modify the mitochondrial genome in live mice, paving the way for new treatments for incurable mitochondrial...


Read more at: Cambridge spin-out aims to realise the power of genomic data in precision medicine

Cambridge spin-out aims to realise the power of genomic data in precision medicine

7 February 2022

Cambridge spin-out Zetta Genomics has raised £2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its genomic data management technology and power the discovery and delivery of precision medicine at scale. XetaBase is built on the open-source OpenCB platform, the first proven...